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DDiscussion
Dr R. Morton Bolman (Boston, Mass). This is a nice study ex-
amining the effect of surgeon volume on outcomes after both on-
pump CABG and OPCAB. Your findings that the median volumes
were 105 cases per surgeon were interesting and represented that
this was a relatively unusual population in that regard. There was
an incidence of 38% ofOPCAB in this population, which is approx-
imately twice the percentage across the Society of Thoracic Sur-
geons’ database in the United States. In that light, do you think
this is representative of what is going on across the United States
in terms of your outcome?
Dr LaPar (Charlottesville, Va). Those are important observa-
tions in our data. I would absolutely echo the fact that the higher
percentage or high proportion of OPCAB cases represented in
this analysis is higher than in other reported series. It may not nec-
essarily be representative of what is occurring nationwide. As I
mentioned, we did have to exclude some states that didn’t report,
and that may have skewed the data in some respect. However,
skewing that data may have helped us to detect subtle relationships
and to quantify the surgeon–outcome relationship, because it al-
lowed us to analyze a higher percentage of OPCAB cases.
Dr Bolman. As you mentioned, you found that patients under-
going operations between the surgeons with the highest and lowest
volume off-pump experience might have as much as a 5% differ-
ence in outcome, and approximately 3% for on-pump. Looking
at this with an eye to improving performance of OPCAB across
the board, would you comment on how you might use these data
going forward? What do you recommend? First, is there a volume
of OPCAB that a surgeon should be doing? You gave some general
ideas there. But if a surgeon is not performing more than 30 or 40
CABGs per year, should he/she do on-pump versus off-pump?
Dr Lapar. Those are both important points. I wasn’t necessarily
surprised to see that there was a statistically significant surgeon–
volume relationship for OPCAB. That is fairly well known. One
of the important points is that the difference in the adjusted prob-
ability of death that occurs from low- to high-volume surgeons
falls in a continuum of anywhere from 1% to 5%. The 5% value
that we noted on the top end was for 1 year, and that year was
back near the beginning of our analysis.
In terms of recommendations, I would be hesitant, on the basis of
an observational study like this, to recommend a specific threshold
for surgeons to strive for, especially in light of the fact that although
this is a statistically significant relationship, the strength of associ-
ations is lower than other factors, even, for example, hypertension.
Dr Bolman. Finally, if you look at this conversely, is there
a mechanism whereby surgeon or system performance can be
improved even for lower-volume surgeons and programs to the
level observed in the higher-volume programs, by focusing on
quality, for example, the National Quality Forum standards? I raise
this issue because of the earlier article by Kurlansky and col-
leagues, where they found no correlation between volume and out-
come for CABG across the board and found that quality issuesThe Journal of Thoracic and Cawere more important than volume. Would you care to comment
on that?
Dr Lapar. Of course, quality issues, as you mentioned, are dif-
ficult to assess in a study like this, but we would recommend cen-
ters that are proven centers of excellence in this respect, regardless
of their volume.
Dr Bolman. This type of comparative effectiveness research is
extremely important as we look at the adoption of new techniques.
DrRichardShemin (Los Angeles,Calif). Very nice study.Do you
have any data to suggest that low-volume OPCAB surgeons perform
operations in higher-risk patients and that thehigher-volume surgeons
have a better distribution of the other risk factors in their cohorts?
Dr Lapar. No, we don’t have those data, and we didn’t analyze
the data that we do have with respect to that. That is an important
observation, though. I would suspect that higher-volume surgeons
have a wider distribution in the patients they see, and it may even
be that low-volume surgeons, although patients may be at high or
low risk, are a factor.
DrGregory Hirsch (Halifax, NS, Canada). Congratulations on
an excellent study. From time to time, we have used administrative
data in Canada for a Pan-Canadian look at various problems using
Canadian Institutes ofHealth information data, andwe have always
been concerned about data quality and accuracywhenever possible,
and in 1 to 3 provinces, we can invariably seek to validate the data-
set we have with detailed observational data. Did you have any op-
portunity to do thatwhen there is a statewide initiative, and there are
several in the United States, to match up your observational data?
Dr Lapar. You point out an important limitation in secondary
analyses of administrative databases. Currently we haven’t had
a chance to validate these results in any sort of a surgical database
or a more specific quality initiative database. We do have a state
quality initiative database that provides Society of Thoracic Sur-
geons’ data within the Commonwealth of Virginia. However, our
decision to use this particular administrative database is surely
to obtain a reasonable sample size fromwhich to analyze this ques-
tion. The database that we have access to currently just didn’t have
sufficient numbers to do that. I do think this should be validated in
a larger nationwide surgical database, such as the Society of Tho-
racic Surgeons’ adult cardiac database, if possible.
DrValavanur Subramanian (New York, NY). Several years ago
at this society’s annual meeting, we presented the incremental risk
of emergencyOPCABconversion onmortality andmorbidity in our
own large database. Is there any way to identify the conversion in
this national database sample? A low-volume surgeon perhaps
may have a higher emergency conversion contributing to higher
mortality correlation to surgical volume. A reduction in conversion
rate inOPCABby routine use of intracoronary shunt and cardiac po-
sitioning device may be helpful. This is an earlier study, and most
people would use a positioning device. Do you have any comment?
Dr Lapar.Within this database, it would be possible to come up
with a scheme to identify within the same hospitalization whether
or not a patient had 1 or both operations. As we discussed earlier in
the afternoon in a similar study, there are some procedure variables
within the NIS dataset that allow you to identify the day that oper-
ations are performed. But I think using those in a setting like this
makes some broad assumptions that I don’t know if I feel comfort-
able doing. I think those questions are better addressed with more
specific surgical databases.rdiovascular Surgery c Volume 143, Number 4 863
